ロード中...

Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats

Cebranopadol is a novel agonist of nociceptin/orphanin FQ peptide (NOP) and opioid receptors with analgesic properties that is being evaluated in clinical Phase 2 and Phase 3 trials for the treatment of chronic and acute pain. Recent evidence indicates that the combination of opioid and NOP receptor...

詳細記述

保存先:
書誌詳細
出版年:J Pharmacol Exp Ther
主要な著者: de Guglielmo, Giordano, Matzeu, Alessandra, Kononoff, Jenni, Mattioni, Julia, Martin-Fardon, Rémi, George, Olivier
フォーマット: Artigo
言語:Inglês
出版事項: The American Society for Pharmacology and Experimental Therapeutics 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5539589/
https://ncbi.nlm.nih.gov/pubmed/28645915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.117.241042
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!